BioXcel Therapeutics, Inc. (BTAI) Dialogue of Managing Acute Agitation in Schizophrenia and Bipolar Problems at Dwelling Transcript

Vimal Mehta
Founder, CEO, President, & Director

Good morning, everybody, and thanks for becoming a member of us immediately. I want to begin by welcoming our distinguished contributors. We’re grateful to every of you for bringing your deep expertise within the agitation area to assist us form this vital dialogue. Your insights are important as we proceed working to enhance look after the tens of millions of sufferers and households managing acute agitation related to schizophrenia and bipolar problems within the house setting.

I might additionally prefer to thank our moderator, Anjalee Khemlani, an award-winning journalist identified for our considerate and in-depth reporting on well being care. We’re delighted to have her information immediately’s dialog and introduce the scientific specialists who might be sharing their perspective.

An episodes of acute agitation stay a major problem, particularly for these navigating them outdoors scientific setting, the necessity for sensible patient-centered innovation has by no means been clearer. At the moment’s roundtable displays our dedication to advancing options that may assist cut back the burden on sufferers, caregivers and the well being care system as an entire. Our mission at BioXcel Therapeutics is to rework affected person care and conversations just like the one we’re about to have play a significant function in shaping the way forward for how agitation is acknowledged and managed in real-world setting. With that, I want to flip it over to Anjalee to start the dialogue.

Anjalee Khemlani

Thanks a lot for that introduction, Vimal, and a pleasure to be right here with you all immediately. As famous, I’m a well being care journalist and have been